Company Profile

Clontech Laboratories Inc
Profile last edited on: 4/2/19      CAGE:       UEI:

Business Identifier: Molecular biology tools supplier enabling gene discovery research
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1290 Terra Bella Avenue
Mountain View, CA 94043
   (650) 650-9197300
Location: Single
Congr. District: 18
County: Santa Clara

Public Profile

Originally acquired by Becton Dickinson in 1999, in 2005 - with Clontech Laboratories was no longer a good match to BD - the firm was sold to Takara Bio. and is now a wholly-owned subsidiary of Takara Bio Inc., developing, manufacturing, and distributing a wide range of life science research reagents under the Clontech® and Takara® brands. Key products include SMARTer® cDNA synthesis kits for a variety of samples and applications, including NGS; high-performance qPCR and PCR reagents (including the TaKaRa Ex Taq®, TaKaRa LA Taq®, Titanium®, and Advantage® enzymes); RT enzymes and SMART library construction kits; the innovative In-Fusion® cloning system; Tet-based inducible gene expression systems; Living Colors® fluorescent proteins; and a range of Macherey-Nagel nucleic acid purification

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1998 1 NIH $70,000
Project Title: Cell Based Screening Assay To Detect Nf-Kb Activation
1997 1 NIH $100,000
Project Title: In Vivo Detection Of Protein/Protein Interaction
1997 1 NIH $100,000
Project Title: Ice Family Protease Assay In Apoptosis
1997 1 NIH $100,000
Project Title: Polymerase Chain Reactionassay For Delta Lf In Cancer
1997 1 NIH $100,000
Project Title: Generation and use of Recombinant Delta Lactoferrin

Key People / Management

  Kenneth Fong -- President

  Dong Xu Yin